Skip to content

Metabolic

hGH Fragment 176-191

Also called HGH Frag 176-191, Somatropin fragment 176-191

InjectableEvidence CEvery day
Half-life
0.5hours
Typical vial
5 / 10mg
Research amounts
250–500mcg

per administration

Common schedule
Every day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded15units dialled
Concentration
1.67mg/mL
Volume per draw
0.15mL
Units to dial
15
Doses per cartridge
20

Vial label

Copy this into your label printer.

Published research contexts for hGH Fragment 176-191 describe 250500 mcg per administration. Descriptive only, not a recommendation.

Short in plasma; human pharmacokinetics for the bare fragment are thin.

The unmodified C-terminal fragment of growth hormone, distinct from the stabilised analog AOD-9604 listed separately. No human dose-ranging study fixes an injected amount or schedule; circulating figures are community-derived, so no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
3hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • hGH 176-191 fragment preclinical literatureLipolytic activity described in rodent and in-vitro work; the bare fragment's human amounts are community-derived, not trial-established.

Next steps